| Year |
Citation |
Score |
| 2020 |
Senbanjo LT, AlJohani H, AlQranei M, Majumdar S, Ma T, Chellaiah MA. Identification of sequence-specific interactions of the CD44-intracellular domain with RUNX2 in the transcription of matrix metalloprotease-9 in human prostate cancer cells. Cancer Drug Resistance (Alhambra, Calif.). 3: 586-602. PMID 33062960 DOI: 10.20517/cdr.2020.21 |
0.397 |
|
| 2020 |
AlQranei MS, Aljohani H, Majumdar S, Senbanjo LT, Chellaiah MA. C-phycocyanin attenuates RANKL-induced osteoclastogenesis and bone resorption in vitro through inhibiting ROS levels, NFATc1 and NF-κB activation. Scientific Reports. 10: 2513. PMID 32054921 DOI: 10.1038/S41598-020-59363-Y |
0.369 |
|
| 2019 |
Aljohani H, Senbanjo LT, Chellaiah MA. Methylsulfonylmethane increases osteogenesis and regulates the mineralization of the matrix by transglutaminase 2 in SHED cells. Plos One. 14: e0225598. PMID 31805069 DOI: 10.1371/journal.pone.0225598 |
0.319 |
|
| 2019 |
Senbanjo LT, AlJohani H, Majumdar S, Chellaiah MA. Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells. Cell Communication and Signaling : Ccs. 17: 80. PMID 31331331 DOI: 10.1186/s12964-019-0395-6 |
0.481 |
|
| 2018 |
Srinivasan D, Senbanjo L, Majumdar S, Franklin RB, Chellaiah MA. Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2. Journal of Cellular Biochemistry. PMID 30206982 DOI: 10.1002/jcb.27573 |
0.423 |
|
| 2017 |
Senbanjo LT, Chellaiah MA. CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells. Frontiers in Cell and Developmental Biology. 5: 18. PMID 28326306 DOI: 10.3389/Fcell.2017.00018 |
0.518 |
|
| 2013 |
Gupta A, Zhou CQ, Chellaiah MA. Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells. Cancers. 5: 617-38. PMID 24216994 DOI: 10.3390/Cancers5020617 |
0.526 |
|
| 2013 |
Chellaiah MA, Ma T. Membrane localization of membrane type 1 matrix metalloproteinase by CD44 regulates the activation of pro-matrix metalloproteinase 9 in osteoclasts. Biomed Research International. 2013: 302392. PMID 23984338 DOI: 10.1155/2013/302392 |
0.549 |
|
| 2013 |
Gupta A, Cao W, Sadashivaiah K, Chen W, Schneider A, Chellaiah MA. Promising noninvasive cellular phenotype in prostate cancer cells knockdown of matrix metalloproteinase 9. Thescientificworldjournal. 2013: 493689. PMID 23476138 DOI: 10.1155/2013/493689 |
0.558 |
|
| 2012 |
Gupta A, Cao W, Chellaiah MA. Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis. Molecular Cancer. 11: 66. PMID 22966907 DOI: 10.1186/1476-4598-11-66 |
0.504 |
|
| 2010 |
Robertson BW, Bonsal L, Chellaiah MA. Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells. Molecular Cancer. 9: 260. PMID 20868520 DOI: 10.1186/1476-4598-9-260 |
0.469 |
|
| 2010 |
Ma T, Sadashivaiah K, Madayiputhiya N, Chellaiah MA. Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts. The Journal of Biological Chemistry. 285: 29911-24. PMID 20650888 DOI: 10.1074/Jbc.M109.099697 |
0.335 |
|
| 2009 |
Desai B, Ma T, Zhu J, Chellaiah MA. Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface. Journal of Cellular Biochemistry. 108: 272-84. PMID 19582779 DOI: 10.1002/Jcb.22248 |
0.668 |
|
| 2009 |
Chellaiah MA, Schaller MD. Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro. Journal of Cellular Physiology. 220: 382-93. PMID 19350555 DOI: 10.1002/Jcp.21777 |
0.409 |
|
| 2008 |
Desai B, Ma T, Chellaiah MA. Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion. The Journal of Biological Chemistry. 283: 13856-66. PMID 18337256 DOI: 10.1074/Jbc.M709401200 |
0.655 |
|
| 2008 |
Ma T, Samanna V, Chellaiah MA. Dramatic inhibition of osteoclast sealing ring formation and bone resorption in vitro by a WASP-peptide containing pTyr294 amino acid. Journal of Molecular Signaling. 3: 4. PMID 18289379 DOI: 10.1186/1750-2187-3-4 |
0.337 |
|
| 2007 |
Samanna V, Ma T, Mak TW, Rogers M, Chellaiah MA. Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function. Journal of Cellular Physiology. 213: 710-20. PMID 17508356 DOI: 10.1002/Jcp.21137 |
0.601 |
|
| 2007 |
Desai B, Rogers MJ, Chellaiah MA. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells Molecular Cancer. 6. PMID 17343740 DOI: 10.1186/1476-4598-6-18 |
0.685 |
|
| 2007 |
Chellaiah MA, Kuppuswamy D, Lasky L, Linder S. Phosphorylation of a Wiscott-Aldrich syndrome protein-associated signal complex is critical in osteoclast bone resorption. The Journal of Biological Chemistry. 282: 10104-16. PMID 17283076 DOI: 10.1074/Jbc.M608957200 |
0.373 |
|
| 2006 |
Chellaiah MA. Regulation of podosomes by integrin alphavbeta3 and Rho GTPase-facilitated phosphoinositide signaling. European Journal of Cell Biology. 85: 311-7. PMID 16460838 DOI: 10.1016/J.Ejcb.2006.01.008 |
0.335 |
|
| 2005 |
Chellaiah MA. Regulation of actin ring formation by rho GTPases in osteoclasts. The Journal of Biological Chemistry. 280: 32930-43. PMID 16006560 DOI: 10.1074/Jbc.M500154200 |
0.347 |
|
| 2004 |
Biswas RS, Baker D, Hruska KA, Chellaiah MA. Polyphosphoinositides-dependent regulation of the osteoclast actin cytoskeleton and bone resorption. Bmc Cell Biology. 5: 19. PMID 15142256 DOI: 10.1186/1471-2121-5-19 |
0.35 |
|
| 2003 |
Chellaiah MA, Biswas RS, Rittling SR, Denhardt DT, Hruska KA. Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption in osteoclasts. The Journal of Biological Chemistry. 278: 29086-97. PMID 12730217 DOI: 10.1074/Jbc.M211074200 |
0.472 |
|
| 2003 |
Gupta A, Lee BS, Khadeer MA, Tang Z, Chellaiah M, Abu-Amer Y, Goldknopf J, Hruska KA. Leupaxin is a critical adaptor protein in the adhesion zone of the osteoclast. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 18: 669-85. PMID 12674328 DOI: 10.1359/Jbmr.2003.18.4.669 |
0.4 |
|
| 2003 |
Chellaiah MA, Kizer N, Biswas R, Alvarez U, Strauss-Schoenberger J, Rifas L, Rittling SR, Denhardt DT, Hruska KA. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Molecular Biology of the Cell. 14: 173-89. PMID 12529435 DOI: 10.1091/Mbc.E02-06-0354 |
0.417 |
|
| 2003 |
Chellaiah MA, Hruska K. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcified Tissue International. 72: 197-205. PMID 12469249 DOI: 10.1007/S00223-002-1025-6 |
0.488 |
|
| Show low-probability matches. |